熱門資訊> 正文

萨瓦拉公司在收购猜测中，

2025-12-03 03:39

Mast Therapeutics, Inc.(SVRA) 0

Savara Inc. (SVRA) pared a loss and ticked higher by 0.2% amid takeover speculation.
There's speculation that Savara may have attracted takeover interest, according to traders, who cited a Betaville "uncooked" alert that was circulating on Tuesday. The identity of the potential buyer wasn't known.
Shares of Savara (SVRA) have risen more than 80% this year. The biotech has a market cap of $1.4 billion.

More on Savara

Savara: A High-Risk Opportunity
Savara: Back On Track With Upcoming APAP BLA Filing
Savara prices $130M equity at $4.20
Savara announces proposed public offering
Seeking Alpha’s Quant Rating on Savara

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。